Parkinson's

News

Intec Pharma shares dive after Parkinson's trial failure

Intec Pharma’s Parkinson’s gradual release disease drug trial has missed its primary endpoint, causing the biotech’s share price to crash.

News

Musk's Neuralink close to clinical trials of "brain interfac...

A new brain implant technology from Elon Musk’s tech startup Neuralink could be used as a treatment for neurologic conditions and Parkinson’s disease.

News

FDA fast tracks Prevail's Parkinson's gene therapy

The FDA has fast tracked a gene therapy for a certain form of Parkinson’s Disease from US biotech Prevail Therapeutics.

News

Charity backs R&D into Parkinson's drugs targeting mitochond...

The charity Parkinson’s UK has struck a £1 million partnership with NRG Therapeutics to develop drugs targeted at mitochondria that could protect cells producing dopamine, which have been d

Views & Analysis

Success comes from listening to and working with patients

With the current mainstay of Parkinson’s treatment being more than 50 years old and doing nothing to slow or halt the progressive disease, the community is crying out for new drugs.

News